Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chondrex is a privately held company that manufactures and distributes validated reagents (e.g., purified collagens, monoclonal antibodies, ELISA kits) for preclinical research in inflammation, autoimmunity, and connective tissue diseases. It is not a therapeutics or drug development company, focusing instead on supporting experimental research models rather than clinical drug development. The company distinguishes itself with deep expertise in immunology and collagen biochemistry, offering custom assay services and rapid technical support, with products distributed internationally. Founded in 1996, it is a small company with 9 employees, located in Woodinville, Washington.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chondrex.